Abstract
Cross-linked starch microspheres were prepared using different kinds of cross-linking agents. The influence of several parameters on morphology, size, swelling ratio and drug release rate from these microspheres were evaluated. These parameters included cross-linker type, concentration and the duration of cross-linking reaction. Microspheres cross-linked with glutaraldehyde had smooth surface compared with those prepared with epichlorhydrine or formaldehyde. The particle size increased with increasing the cross-linking time and increasing the drug loading. Swelling ratio of the particles was a function of cross-linker type but not the concentration or time of cross-linking. Drug release from starch microspheres was measured in phosphate buffer and also in phosphate buffer containing a-amylase. Results showed that microspheres cross-linked with epichlorhydrine released all their drug content in the first 30 minutes. However, cross-linking of the starch microspheres with glutaraldehyde or formaldehyde decreased drug release rate. SEM and drug release studies showed that cross-linked starch microspheres were susceptible to the enzymatic degradation under the influence of alpha-amylase. Changing the enzyme concentration from 5000 to 10,000 IU/L, increased drug release rate but higher concentration of enzyme (20,000 IU/L) caused no more acceleration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Atyabi, F., Inanloo, K., and Dinarvand, R., Bovine serum albumin-loaded pectinate beads as colonic peptide delivery system: Preparation and in vitro characterization.Drug Deliv., 12, 367–375 (2005a).
Atyabi, F., Majzoob, S., Iman, M., Salehi, M., and Dorkoosh, F., In vitro evaluation and modification of pectinate gel beads containing trimethyl chitosan, as a multi-particulate system for delivery of water-soluble macromolecules to colon.Carbohydr. Polym., 61, 39–51 (2005b).
Azevedo, H. S., Gama, F. M., and Reis, R. L., In vitro assessment of the enzymatic degradation of several starch based biomaterials.Biomacromolecules, 4, 1703–1712 (2003).
Brena, B. M., Pazos, C., Franco-Fraguas, L., and Batista-Viera, F., Chromatographic methods for amylases.J. Chromatogr. B. Biomed. Appl., 684, 217–237 (1996).
Chawla, V., Tiwary, A. K., and Gupta, S., Characterization of polyvinylalcohol microspheres of diclofenac sodium: Application of statistical design.Drug Dev. Ind. Pharm., 26, 675–680 (2000).
Dumoulin, Y., Carriere, F., and Ingenito, A., Manufacture of cross-linked amylose useful as a excipient for control release of active compounds.U.S. Patents, US5807575 (1998).
Hamdi, G. and Ponchel, G., Enzymatic degradation of epichlorohydrin crosslinked starch microspheres by α-amylase.Pharmaceutical Research, 16, 867–875 (1999).
Hamdi, G., Ponchel, G., and Duchene, D., An original method for studying in vitro the enzymatic degradation of cross-linked starch microspheres.J. Control. Release, 55, 193–201 (1998).
Hamdi, G., Ponchel, G., and Duchene, D., Formulation of epichlorohydrin cross-linked starch microspheres.J. Microencapsul., 18, 373–383 (2001).
Kost, J. and Shefer, S., Chemically-modified polysaccharides for enzymatically-controlled oral drug delivery.Biomaterials, 11, 695–698 (1990).
Lee, S. J., and Rosenberg, M., Preparation and properties of glutaraldehyde cross-linked whey protein-based microcapsules containing theophylline.J. Control. Release, 61, 123–136 (1999).
Lenaerts, V., Chouinard, F., Mateescu, M. A., and Ispas-Szabo, P., Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds.U.S. Patents, US6284273 (2001).
Lenaerts, V., Moussa, I., Dumoulin, Y., Mebsout, F., Chouinard, F., Szabo, P., Mateescu, M. A., Cartilier, L., and Marchessault, R., Cross-linked high amylose starch for controlled release of drugs: Recent advances.J. Control. Release, 53, 225–234 (1998).
Mulhbacher, J., Ispas-Szabo, P., Lenaerts, V., and Mateescu, M. A., Cross-linked high amylose starch derivatives as matrices for controlled release of high drug loadings.J. Control. Release, 76, 51–58 (2001).
Mulhbacher, J., Ispas-Szabo, P., and Mateescu, M. A., Cross-linked high amylose starch derivatives for drug release: II. Swelling properties and mechanistic study.Int. J. Pharm., 278, 231–238 (2004).
Mulhbacher, J. and Mateescu, M. A., Cross-linked high amylose starch derivatives for drug release: III. Diffusion properties.Int. J. Pharm., 297, 22–29 (2005).
Rahmouni, M., Chouinard, F., Nekka, F., Lenaerts, V., and Leroux, J. C., Enzymatic degradation of cross-linked high amylose starch tablets and its effect on in vitro release of sodium diclofenac.Eur. J. Pharm. Biopharm., 51, 191–198 (2001).
Rahmouni, M., Lenaerts, V., Massuelle, D., Doelker, E., Johnson, M., and Leroux, J. C., Characterization of Binary Mixtures Consisting of Cross-Linked High Amylose Starch and Hydroxypropylmethylcellulose Used in the Preparation of Controlled Release Tablets.Pharm. Dev. Technol., 8, 335–348 (2003).
Soppirnath, K. S. and Aminabhavi, T. M., Water transport and drug release study from cross-linked polyacrylamide grafted guar gum hydrogel microspheres for the controlled release application.Eur. J. Pharm. Biopharm., 53, 87–98 (2002).
Vincent, L., Chouinard, F., Mateescu, M. A., and Ispas-Szabo, P., Cross-linked high amylose starch having functional groups as a matrix for the slow release of pharmaceutical agents.European Patents, EP1059915 (2000).
Watts, P., Colonic drug delivery composition.U.S. Patents, US6228396 (2001).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Atyabi, F., Manoochehri, S., Moghadam, S.H. et al. Cross-linked starch microspheres: Effect of cross-linking condition on the microsphere characteristics. Arch Pharm Res 29, 1179–1186 (2006). https://doi.org/10.1007/BF02969311
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02969311